FDA authorizes second bivalent COVID boosters for seniors, other at-risk groups
The Food and Drug Administration (FDA) authorized second bivalent (two-strain) COVID-19 booster doses for people ages 65 and up and for those with weakened immune systems April 19, a step designed to shore up immunity in the most vulnerable groups until fall.